![Applying Acoustic Mass Spectrometry Technology to Biochemical Screening and Beyond Applying Acoustic Mass Spectrometry Technology to Biochemical Screening and Beyond](https://cdn.sanity.io/images/f5b6mtfn/selectscience-prod/f4c576e0ffc725ab456d8440eeedd0d647a0dc3c-1920x1080.png?w=3840&q=75&fit=clip&auto=format)
Applying Acoustic Mass Spectrometry Technology to Biochemical Screening and Beyond
19 Dec 2018
Dr. Jonathan Wingfield , Principal Scientist at AstraZeneca, discusses the development of acoustic mass spectrometry technology for high-throughput screening. Through the combination of acoustic technology from Labcyte and mass spectrometry systems from Waters, acoustic mass spectrometry provides rapid sample processing and analysis of a wide range of molecular targets, saving crucial time and reagents costs needed to screen millions of compounds within AstraZeneca’s small molecule and discovery programs.